Tissue characterization of locoregionally advanced head-and-neck squamous cell carcinoma (HNSCC) using quantified ultrasonography: A prospective phase II study on prognostic relevance

Radiotherapy and Oncology

Volumn 85, Issue 1, 2007, Pages 48-57

  Röper, Barbara ^a   Nüse, Nadine ^a   Busch, Raymonde ^b   Zimmermann, Frank Bodo ^a   Nährig, Jörg ^c   Molls, Michael ^a  

^a Department of Radiotherapy and Radiation Oncology ^*  (Germany)

^b Institute for Medical Statistics and Epidemiology   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biological imaging; Head and neck neoplasms; Lymphatic metastasis; Prognostic factor; Prospective studies; Ultrasonography

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; IMAGING; LYMPH NODE METASTASIS; MALE; MEDICAL DECISION MAKING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 84858372039     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.04.003     Document Type: Article

References (43)

1. Ahuja A.T., Ying M., Ho S.S., and Metreweli C. Distribution of intranodal vessels in differentiating benign from metastatic neck nodes. Clin Radiol 56 (2001) 197-201
2. Bentzen S.M., Atasoy B.M., Daley F.M., et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 23 (2005) 5560-5567
3. Brandwein-Gensler M., Teixeira M.S., Lewis C.M., et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29 (2005) 167-178
4. Budach V., Stuschke M., Budach W., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23 (2005) 1125-1135
5. Bundgaard T., Rossen K., Henriksen S.D., Charabi S., Sogaard H., and Grau C. Histopathologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity. Head Neck 24 (2002) 656-660
6. Chikui T., Yonetsu K., and Nakamura T. Multivariate feature analysis of sonographic findings of metastatic cervical lymph nodes: contribution of blood flow features revealed by power Doppler sonography for predicting metastasis. AJNR Am J Neuroradiol 21 (2000) 561-567
7. Cole I., Chu J., Kos S., and Motbey J. Metastatic carcinoma in the neck: a clinical computerized tomography scan and ultrasound study. Aust N Z J Surg 63 (1993) 468-474
8. Daly T., Poulsen M.G., Denham J.W.H., et al. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Radiother Oncol 68 (2003) 113-122
9. Delorme S., Dietz A., Rudat V., Zuna I., Bahner M.L., and van Kaick G. Prognostic significance of color Doppler findings in head and neck tumors. Ultrasound Med Biol 23 (1997) 1311-1317
10. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
11. Dietz A., Delorme S., Rudat V., et al. Prognostic assessment of sonography and tumor volumetry in advanced cancer of the head and neck by use of doppler ultrasonography. Otolaryngol Head Neck Surg 122 (2000) 596-601
12. Eriksen J.G., Steiniche T., and Overgaard J. The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study. Radiother Oncol 74 (2005) 93-100
13. Fang F.M., Liu Y.T., Tang Y., Wang C.J., and Ko S.F. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 100 (2004) 425-432
14. Fox S.B., Gasparini G., and Harris A.L. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol 2 (2001) 278-289
15. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
16. Greenberg J.S., Fowler R., Gomez J., et al. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97 (2003) 1464-1470
17. Hoogsteen I.J., Peeters W.J., Marres H.A., et al. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas. Radiother Oncol 76 (2005) 213-218
18. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
19. Jonathan R.A., Wijffels K.I., Peeters W., et al. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 79 (2006) 288-297
20. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
21. Kim M.M., and Califano J.A. Molecular pathology of head-and-neck cancer. Int J Cancer 112 (2004) 545-553
22. Koch W., and Sidransky D. Molecular markers of radiation effectiveness in head and neck squamous cell carcinoma. Semin Radiat Oncol 14 (2004) 130-138
23. Kuhnt T., Mueller A.C., Pelz T., et al. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy. J Cancer Res Clin Oncol 131 (2005) 758-764
24. Kumar S., Pandey M., Lal P., Rastogi N., Maria Das K.J., and Dimri K. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. Radiother Oncol 75 (2005) 186-192
25. Moritz J.D., Ludwig A., and Oestmann J.W. Contrast-enhanced color Doppler sonography for evaluation of enlarged cervical lymph nodes in head and neck tumors. AJR Am J Roentgenol 174 (2000) 1279-1284
26. Na D.G., Lim H.K., Byun H.S., Kim H.D., Ko Y.H., and Baek J.H. Differential diagnosis of cervical lymphadenopathy: usefulness of color Doppler sonography. AJR Am J Roentgenol 168 (1997) 1311-1316
27. Nordsmark M., Bentzen S.M., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
28. Nordsmark M., and Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 43 (2004) 396-403
29. Overgaard J., Eriksen J.G., Nordsmark M., Alsner J., and Horsman M.R. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol 6 (2005) 757-764
30. Peters-Engl C., Frank W., Leodolter S., and Medl M. Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival. Breast Cancer Res Treat 54 (1999) 65-71
31. Plataniotis G.A., Theofanopoulou M.E., Kalogera-Fountzila A., et al. Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys 59 (2004) 1018-1026
32. Sakaguchi T., Yamashita Y., Katahira K., et al. Differential diagnosis of small round cervical lymph nodes: comparison of power Doppler US with contrast-enhanced CT and pathologic results. Radiat Med 19 (2001) 119-125
33. Semrau R., Mueller R.P., Stuetzer H., et al. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1308-1316
34. Sobin L.H., and Wittekind C. TNM classification of malignant tumors, International Union Against Cancer. 5th ed. (1997), John Wiley and Sons, New York
35. Stadler P., Becker A., Feldmann H.J., et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44 (1999) 749-754
36. Steinkamp H.J., Cornehl M., Hosten N., Pegios W., Vogl T., and Felix R. Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy. Br J Radiol 68 (1995) 266-270
37. Sumi M., Ohki M., and Nakamura T. Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 176 (2001) 1019-1024
38. Takeuchi Y., Suzuki H., Omura K., et al. Differential diagnosis of cervical lymph nodes in head and neck cancer by ultrasonography. Auris Nasus Larynx 26 (1999) 331-336
39. Vergeer M.R., Doornaert P., Leemans C.R., Buter J., Slotman B.J., and Langendijk J.A. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 79 (2006) 39-44
40. Woolgar J.A. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 42 (2006) 229-239
41. Wreesmann V.B., Shi W., Thaler H.T., et al. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 22 (2004) 3965-3972
42. Ying M., Ahuja A., and Metreweli C. Diagnostic accuracy of sonographic criteria for evaluation of cervical lymphadenopathy. J Ultrasound Med 17 (1998) 437-445
43. Yonetsu K., Sumi M., Izumi M., Ohki M., Eida S., and Nakamura T. Contribution of doppler sonography blood flow information to the diagnosis of metastatic cervical nodes in patients with head and neck cancer: assessment in relation to anatomic levels of the neck. AJNR Am J Neuroradiol 22 (2001) 163-169